Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.100 | None | 0.983 | 288 | 3 | 1992 | 2020 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.985 | 266 | 5 | 1983 | 2019 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 0.100 | None | 0.993 | 139 | 3 | 1996 | 2019 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.100 | None | 0.986 | 139 | 0 | 1980 | 2019 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.100 | None | 0.975 | 116 | 1 | 1995 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 0.991 | 110 | 1 | 1990 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.899 | 92 | 4 | 1986 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 0.947 | 90 | 2 | 1986 | 2020 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
disease | 0.100 | None | 0.967 | 89 | 3 | 1993 | 2019 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 0.971 | 66 | 0 | 1992 | 2019 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.100 | None | 0.938 | 64 | 0 | 1988 | 2019 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
disease | 0.100 | None | 0.981 | 53 | 1 | 1992 | 2019 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
disease | 0.100 | None | 0.981 | 53 | 0 | 1986 | 2019 | ||||||||
|
homeobox A9 | 0.521 | 0.692 | 4.4E-05 |
|
disease | 0.100 | None | 0.962 | 52 | 0 | 1992 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.980 | 49 | 0 | 1983 | 2019 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.961 | 46 | 0 | 1994 | 2020 | ||||||||
|
C-C motif chemokine receptor 7 | 0.443 | 0.769 | 5.8E-02 |
|
disease | 0.100 | None | 1.000 | 45 | 0 | 1992 | 2019 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
disease | 0.100 | None | 0.933 | 45 | 0 | 2005 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.976 | 41 | 0 | 2005 | 2019 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 1.000 | 39 | 0 | 1987 | 2019 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.974 | 38 | 0 | 2005 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.974 | 38 | 0 | 1989 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.973 | 37 | 0 | 2005 | 2019 | ||||||||
|
promyelocytic leukemia | 0.477 | 0.846 | 0.21 |
|
disease | 0.100 | None | 1.000 | 36 | 1 | 1996 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.100 | None | 1.000 | 33 | 5 | 1992 | 2019 |